Authors:
EWER MS
JAFFE N
RIED H
ZIETZ HA
BENJAMIN RS
Citation: Ms. Ewer et al., DOXORUBICIN CARDIOTOXICITY IN CHILDREN - COMPARISON OF A CONSECUTIVE DIVIDED DAILY DOSE ADMINISTRATION SCHEDULE WITH SINGLE-DOSE (RAPID) INFUSION ADMINISTRATION, Medical and pediatric oncology, 31(6), 1998, pp. 512-515
Authors:
WORTH LL
JAFFE N
BENJAMIN RS
PAPADOPOULOS NE
PATEL S
RAYMOND AK
JIA SF
RODRIGUEZ C
GANO J
GIANAN MA
KLEINERMAN ES
Citation: Ll. Worth et al., PHASE-II STUDY OF RECOMBINANT INTERLEUKIN-1-ALPHA AND ETOPOSIDE IN PATIENTS WITH RELAPSED OSTEOSARCOMA, Clinical cancer research, 3(10), 1997, pp. 1721-1729
Citation: Hl. Ried et al., CRYOPRESERVATION OF SEMEN FROM ADOLESCENT PATIENTS WITH MALIGNANCIES, Medical and pediatric oncology, 28(4), 1997, pp. 322-323
Citation: N. Jaffe et Dm. Jaffe, TUMOR SIZE AND PROGNOSIS IN AGGRESSIVELY TREATED OSTEOSARCOMA, Journal of clinical oncology, 14(8), 1996, pp. 2399-2400
Authors:
COPELAND DR
MOORE BD
FRANCIS DJ
JAFFE N
CULBERT SJ
Citation: Dr. Copeland et al., NEUROPSYCHOLOGIC EFFECTS OF CHEMOTHERAPY ON CHILDREN WITH CANCER - A LONGITUDINAL-STUDY, Journal of clinical oncology, 14(10), 1996, pp. 2826-2835
Authors:
WALL SM
JOHANSEN MJ
MOLONY DA
DUBOSE TD
JAFFE N
MADDEN T
Citation: Sm. Wall et al., EFFECTIVE CLEARANCE OF METHOTREXATE USING HIGH-FLUX HEMODIALYSIS MEMBRANES, American journal of kidney diseases, 28(6), 1996, pp. 846-854
Citation: C. Canpolat et al., IFOSFAMIDE TOLERANCE IN OSTEOSARCOMA PATIENTS PREVIOUSLY TREATED WITHCIS-DIAMMINEDICHLOROPLATINUM-II - RENAL, HEMATOLOGIC, AND NEUROLOGIC OBSERVATIONS, Medical and pediatric oncology, 26(1), 1996, pp. 36-47
Authors:
JOHANSEN MJ
WALL S
JAFFE N
GARDNER M
NEWMAN RA
MADDEN T
Citation: Mj. Johansen et al., HIGH-EFFICIENCY DIALYSIS EFFECTIVELY REMOVES METHOTREXATE IN CANCER-PATIENTS WITH RENAL-FAILURE, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 35-35
Authors:
SHETH DS
YASKO AW
RAYMOND AK
AYALA AG
CARRASCO GH
BENJAMIN RS
JAFFE N
MURRAY JA
Citation: Ds. Sheth et al., CONVENTIONAL AND DEDIFFERENTIATED PAROSTEAL OSTEOSARCOMA - DIAGNOSIS,TREATMENT, AND OUTCOME, Cancer, 78(10), 1996, pp. 2136-2145
Authors:
KLEINERMAN ES
MEYERS PA
RAYMOND AK
GANO JB
JIA SF
JAFFE N
Citation: Es. Kleinerman et al., COMBINATION THERAPY WITH IFOSFAMIDE AND LIPOSOME-ENCAPSULATED MURAMYLTRIPEPTIDE - TOLERABILITY, TOXICITY, AND IMMUNE STIMULATION, Journal of immunotherapy with emphasis on tumor immunology, 17(3), 1995, pp. 181-193
Authors:
JAFFE N
ROTT EJ
WOO SY
MAOR MH
SMITH M
BLACK T
ANDRASSY RJ
Citation: N. Jaffe et al., IS THERE A SAFE THERAPEUTIC WINDOW FOR DELIVERY OF CHEMOTHERAPY PRIORTO INITIATION OF SURGERY AND OR RADIATION-THERAPY FOR TREATMENT OF THE PRIMARY TUMOR IN CHILDREN WITH RHABDOMYOSARCOMA/, International journal of oncology, 7(4), 1995, pp. 855-862
Citation: N. Jaffe et al., CHEMOTHERAPY IN OSTEOSARCOMA - BASIS FOR APPLICATION AND ANTAGONISM TO IMPLEMENTATION - EARLY CONTROVERSIES SURROUNDING ITS IMPLEMENTATION, Hematology/oncology clinics of North America, 9(4), 1995, pp. 825-840
Authors:
WARD V
CLEVELAND C
PORTER T
JAFFE N
BETHKE R
Citation: V. Ward et al., WHO INHERITS THE TRADITION -YORK-FOLKLORE-SOCIETY, ALBANY AND TROY, NY, 1994( PANEL DISCUSSION AT 'FOLKLORE AND THE PEOPLE', CONFERENCE OF THE NEW), New York folklore, 21(1-4), 1995, pp. 39-73
Authors:
KLEINERMAN ES
GANO JB
JOHNSTON DA
BENJAMIN RS
JAFFE N
Citation: Es. Kleinerman et al., EFFICACY OF LIPOSOMAL MURAMYL TRIPEPTIDE (CGP 19835A) IN THE TREATMENT OF RELAPSED OSTEOSARCOMA, American journal of clinical oncology, 18(2), 1995, pp. 93-99
Citation: C. Canpolat et N. Jaffe, WILMS-TUMOR - CURE OF MALIGNANT PLEURAL EFFUSION EXCLUSIVELY WITH CHEMOTHERAPY, Medical and pediatric oncology, 24(4), 1995, pp. 274-277
Citation: Z. Allamki et al., ACUTE URTICARIA AND HEPATITIS COMPLICATING HIGH-DOSE METHOTREXATE THERAPY, Medical and pediatric oncology, 24(2), 1995, pp. 137-140